Doo-Sup Choi, male, molecular biologist and neuroscientist, graduated from the Department of Biochemistry at Yonsei University in Seoul, Korea with Bachelor of Science (1988) and Master of Science (1990). He worked for Samsung (CJ Foods and Chemicals) between 1991-1993. He then completed his Ph.D. at the Louis Pasteur University in Strasbourg, France in 1997. He carried out my Ph.D. research on the neurobiological and developmental roles of novel serotonin 5-HT2B receptors in mice. He performed a two-year postdoctoral research in the field of neuropharmacology of addiction (1997-1998) in the Department of Biopharmaceutical Sciences at University of California San Francisco (UCSF). Following that he joined the Ernest Gallo Clinic and Research Center and the Department of Neurology at UCSF as a staff research scientist (1998-2004) and then a junior faculty member (2004-2005). He carried out groundbreaking research on the genetic, neurobiological, and behavioral aspects of alcoholism using several mouse genetic models that he generated including PKCÎµ inducible transgenic, neuron-specific PKCÎµ transgenic, PKCÎ´ null, and ENT1 null mice. He joined Mayo Clinic College of Medicine in 2005 and has established an innovative and cutting-edge research program by combining mouse genetics, behaviors, proteomics, neurochemistry, and imaging. Dr. Choi has published more than 35 peer-reviewed papers and 3 book chapters. Currently, his main research focuses on adenosine and glutamate signaling in neuron-glial interaction and its implication in alcoholism.